BillionToOne, Inc. (BLLN) stock
BLLNNasdaqServices-Medical LaboratoriesFiscal year ends December 31
$105.15−5.64 (-5.09%)
Close on Nov 13, 2026Market cap $4.96BP/E –Yield –
BillionToOne gross margin
Gross margin is gross profit as a percentage of revenue.
BillionToOne's gross margin for the twelve months ending Sep 30, 2026 was 71.4%. For fiscal 2025 it was 68.3%, against 53.0% the year before.
Annual gross margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 68.3% | +15.3 |
| FY2024 | Dec 31, 2024 | 53.0% | +28.9 |
| FY2023 | Dec 31, 2023 | 24.1% | – |
Quarterly gross margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | 70.9% | +0.9 |
| Q2 FY2026 | Jun 30, 2026 | 70.5% | +5.2 |
| Q1 FY2026 | Mar 31, 2026 | 73.0% | +8.6 |
| Q4 FY2025 | Dec 31, 2025 | 71.4% | +14.4 |
| Q3 FY2025 | Sep 30, 2025 | 69.9% | +17.3 |
| Q2 FY2025 | Jun 30, 2025 | 65.3% | – |
| Q1 FY2025 | Mar 31, 2025 | 64.4% | – |
| Q4 FY2024 | Dec 31, 2024 | 57.1% | – |
| Q3 FY2024 | Sep 30, 2024 | 52.6% | – |
See a number that looks wrong?